Cargando…
COVID-19 vaccine capacity: Challenges and mitigation – The DCVMN perspective
Vaccine manufacturers from developing countries have a proven track record of developing, producing, and supplying high-quality vaccines globally. However, due to the complexity of vaccine manufacturing, numerous stakeholder organizations support manufacturers across a variety of functions. To optim...
Autores principales: | Hayman, Benoit, Suri, Rajinder, Prasad, Sai D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275514/ https://www.ncbi.nlm.nih.gov/pubmed/34325932 http://dx.doi.org/10.1016/j.vaccine.2021.07.007 |
Ejemplares similares
-
Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting
por: Kumar Suri, Rajinder, et al.
Publicado: (2022) -
Global equity and timely access: COVID-19 & beyond 23rd DCVMN Annual General Meeting 2022 report
por: Suri, Rajinder Kumar, et al.
Publicado: (2023) -
Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report()
por: Pagliusi, Sonia, et al.
Publicado: (2021) -
Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia
por: Raffard, Stéphane, et al.
Publicado: (2022) -
Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities
por: Hayman, Benoit, et al.
Publicado: (2021)